A detailed history of Groupama Asset Managment transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Groupama Asset Managment holds 339,405 shares of BHC stock, worth $3.14 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
339,405
Previous 7,431 4467.42%
Holding current value
$3.14 Million
Previous $3.49 Billion 32.22%
% of portfolio
0.03%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.1 - $10.41 $2.03 Million - $3.46 Million
331,974 Added 4467.42%
339,405 $2.37 Billion
Q1 2024

May 14, 2024

SELL
$7.77 - $10.61 $2 Million - $2.74 Million
-257,887 Reduced 97.2%
7,431 $3.49 Billion
Q4 2023

Feb 14, 2024

BUY
$6.53 - $8.23 $1.73 Million - $2.18 Million
265,318 New
265,318 $2.13 Billion

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.35B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.